This inventor holds 2 USPTO granted patents. Top assignee: Cme Telemetrix Inc.. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Paul Drennan: Innovator in Spectral Analysis Technology
Introduction
Paul Drennan is a notable inventor based in Waterloo, Canada. He has made significant contributions to the field of spectral analysis, particularly in the development of devices that enhance the accuracy of non-invasive monitoring technologies. With a total of 2 patents to his name, Drennan's work is paving the way for advancements in medical diagnostics.
Latest Patents
Drennan's latest patents include a device for verifying the accuracy of a spectral analyzer. This invention provides an artificial member that mimics the absorbance spectrum of a body part and incorporates the spectral components of blood analytes. The artificial member is constructed from a light scattering and reflecting material and features a chamber portion that includes one or more chambers. It is designed to be reproducibly received in a measuring receptor, which is operatively connected to a non-invasive monitoring device. Another patent focuses on an artificial member that mimics the absorbance spectrum of an animal body part, also including the spectral components of blood analytes. This device is similarly made from a light scattering and reflecting material and is configured for use with a non-invasive monitoring device.
Career Highlights
Drennan is currently associated with Cme Telemetrix Inc., where he continues to innovate and develop technologies that improve medical monitoring systems. His work is characterized by a commitment to enhancing the accuracy and reliability of spectral analysis.
Collaborations
Some of Drennan's notable coworkers include James Samsoondar and Ashwani Kaushal. Their collaborative efforts contribute to the advancement of technology in the field of non-invasive monitoring.
Conclusion
Paul Drennan's contributions to spectral analysis technology are significant and impactful. His inventions are set to improve the accuracy of medical diagnostics, showcasing his dedication to innovation in healthcare.